[Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
de Haan
R J
RJ
Academisch Medisch Centrum, afd. Klinische Epidemiologie en Biostatistiek, Amsterdam.
Polman
C H
CH
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D004185:Disability Evaluation; D005069:Evaluation Studies as Topic; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000145:classification / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a